ANNEX XVII Table 6: rows 201 - 241
| [X1 [X2Nitrobenzene | 609-003-00-7 | 202-716-0 | 98-95-3 | ] |
| [F1Dinocap (ISO); (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which ‘ octyl ’ is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups | 609-023-00-6 | 254-408-0 | 39300-45-3 | ] |
| Binapacryl (ISO); 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate | 609-024-00-1 | 207-612-9 | 485-31-4 | |
| Dinoseb; 6-sec-butyl-2,4-dinitrophenol | 609-025-00-7 | 201-861-7 | 88-85-7 | |
| Salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex | 609-026-00-2 | |||
| Dinoterb; 2-tert-butyl-4,6-dinitrophenol | 609-030-00-4 | 215-813-8 | 1420-07-1 | |
| Salts and esters of dinoterb | 609-031-00-X | |||
| Nitrofen (ISO); 2,4 dichlorophenyl 4-nitrophenyl ether | 609-040-00-9 | 217-406-0 | 1836-75-5 | |
| Methyl-ONN-azoxymethyl acetate; methyl azoxy methyl acetate | 611-004-00-2 | 209-765-7 | 592-62-1 | |
| 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one | 611-131-00-3 | 420-580-2 | — | |
| Azafenidin | 611-140-00-2 | — | 68049-83-2 | |
| [F2Chloro-N,N-dimethylformiminium chloride | 612-250-00-3 | 425-970-6 | 3724-43-4 | |
| 7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)] | 612-253-01-7 | 429-400-7 | 199327-61-2 | ] |
| [F3Triflumizole (ISO); (1 E )- N -[4-chloro-2-(trifluoromethyl)phenyl]-1-(1 H -imidazol-1-yl)-2-propoxyethanimine | 612-289-00-6 | — | 68694-11-1 | ] |
| Tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine | 613-020-00-5 | 246-347-3 | 24602-86-6 | |
| Ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol | 613-039-00-9 | 202-506-9 | 96-45-7 | |
| Carbendazim (ISO) methyl benzimidazol-2-ylcarbamate | 613-048-00-8 | 234-232-0 | 10605-21-7 | |
| Benomyl (ISO) methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate | 613-049-00-3 | 241-775-7 | 17804-35-2 | |
| Cycloheximide | 613-140-00-8 | 200-636-0 | 66-81-9 | |
| [F4Flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione | 613-166-00-X | — | 103361-09-7 | ] |
| (2RS,3RS)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)-methyl]oxirane | 613-175-00-9 | 406-850-2 | 106325-08-0 | |
| [X2Epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1 H -1,2,4-triazol-1-yl)methyl]oxirane | 613-175-00-9 | 406-850-2 | 133855-98-8 | ] |
| 3-Ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine | 613-191-00-6 | 421-150-7 | 143860-04-2 | |
| A mixture of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione; a mixture of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione | 613-199-00-X | 421-550-1 | — | |
| [F2Ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | 613-283-00-6 | 265-667-4 | 65277-42-1 | |
| Potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | 613-286-01-X | 418-260-2 | 183196-57-8 | ] |
| [F3Imidazole | 613-319-00-0 | 206-019-2 | 288-32-4 | ] |
| [F5Triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol | 613-322-00-7 | 259-537-6 | 55219-65-3 | |
| Quinolin-8-ol; 8-hydroxyquinoline | 613-324-00-8 | 205-711-1 | 148-24-3 | |
| Thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide | 613-325-00-3 | — | 111988-49-9 | ] |
| N, N-dimethylformamide; dimethyl formamide | 616-001-00-X | 200-679-5 | 68-12-2 | |
| N, N-Dimethylacetamide | 616-011-00-4 | 204-826-4 | 127-19-5 | [F6E] |
| Formamide | 616-052-00-8 | 200-842-0 | 75-12-7 | |
| N-methylacetamide | 616-053-00-3 | 201-182-6 | 79-16-3 | |
| N-methylformamide | 616-056-00-X | 204-624-6 | 123-39-7 | [F6E] |
| [F2N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide | 616-148-00-X | 424-550-1 | 84245-12-5 | |
| N,N-(dimethylamino)thioacetamide hydrochloride | 616-180-00-4 | 435-470-1 | 27366-72-9 | ] |
| [X2N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one | 616-208-00-5 | 220-250-6 | 2687-91-4 | ] |
| [F5Carbetamide (ISO); (R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate | 616-223-00-7 | 240-286-6 | 16118-49-3 | ] |
| [X2Pitch, coal tar, high-temp.; (The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.) | 648-055-00-5 | 266-028-2 | 65996-93-2 | ] |
| [F5Cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | 650-032-00-X | — | 94361-06-5 | ] ] |
Editorial Information
X1Substituted by Corrigendum to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (Official Journal of the European Union L 396 of 30 December 2006).
X2 Substituted by Corrigendum to Commission Regulation (EU) 2018/589 of 18 April 2018 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards methanol (Official Journal of the European Union L 99 of 19 April 2018).
Textual Amendments
F1 Inserted by Commission Regulation (EU) 2018/589 of 18 April 2018 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards methanol (Text with EEA relevance).
F2 Substituted by Commission Regulation (EU) No 494/2011 of 20 May 2011 amending Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards Annex XVII (Cadmium) (Text with EEA relevance).
F3 Inserted by Commission Regulation (EU) 2018/35 of 10 January 2018 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards octamethylcyclotetrasiloxane (‘D4’) and decamethylcyclopentasiloxane (‘D5’) (Text with EEA relevance).
F4 Inserted by Commission Regulation (EU) 2020/1149 of 3 August 2020 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards diisocyanates (Text with EEA relevance).
F5 Inserted by Commission Regulation (EU) 2018/1513 of 10 October 2018 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards certain substances classified as carcinogenic, mutagenic or toxic for reproduction (CMR), category 1A or 1B (Text with EEA relevance).
F6 Inserted by Commission Regulation (EU) 2017/1000 of 13 June 2017 amending Annex XVII to Regulation (EC) No 1907/2006 oNf the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards perfluorooctanoic acid (PFOA), its salts and PFOA-related substances (Text with EEA relevance).